Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
The Journal of Biological Chemistry
|
October 25, 2011
Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells
Inamul Haque, Snigdha Banerjee, Smita Mehta, et al.
Molecular Cancer Therapeutics
|
March 4, 2010
2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis
Suman Kambhampati, Snigdha Banerjee, Kakali Dhar, et al.
Pharmacology Research & Perspectives
|
March 21, 2021
CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression
Amlan Das, Inamul Haque, Priyanka Ray, et al.
Biopolymers
|
October 6, 2009
Identifying protein stabilizing ligands using GroEL
Subhashchandra Naik, Inamul Haque, Nick Degner, et al.
Molecular Cancer Therapeutics
|
January 5, 2013
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model
Suman Kambhampati, Roger A Rajewski, Mehmet Tanol, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
September 26, 2021
SIGIRR Mutation in Human Necrotizing Enterocolitis (NEC) Disrupts STAT3-Dependent microRNA Expression in Neonatal Gut
Wei Yu, Inamul Haque, Aparna Venkatraman, et al.
The Journal of Biological Chemistry
|
February 8, 2018
The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling
Gargi Maity, Inamul Haque, Arnab Ghosh, et al.
Research Square
|
June 5, 2025
Targeted Nanoencapsulation of Tunicamycin Reduces Toxicity While Improving its Therapeutic Effectiveness in Pancreatic Cancer Cells
Debasmita Dutta, Sunil Upadhyay, Archana De, et al.
Molecular Therapy. Oncology
|
October 2, 2025
Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic cancer cells
Debasmita Dutta, Sunil P Upadhyay, Archana De, et al.
Molecular Cancer Therapeutics
|
February 22, 2019
CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma
Gargi Maity, Arnab Ghosh, Vijayalaxmi Gupta, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
The Journal of Biological Chemistry
|
October 25, 2011
Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells
Inamul Haque, Snigdha Banerjee, Smita Mehta, et al.
Molecular Cancer Therapeutics
|
March 4, 2010
2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis
Suman Kambhampati, Snigdha Banerjee, Kakali Dhar, et al.
Pharmacology Research & Perspectives
|
March 21, 2021
CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression
Amlan Das, Inamul Haque, Priyanka Ray, et al.
Biopolymers
|
October 6, 2009
Identifying protein stabilizing ligands using GroEL
Subhashchandra Naik, Inamul Haque, Nick Degner, et al.
Molecular Cancer Therapeutics
|
January 5, 2013
A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model
Suman Kambhampati, Roger A Rajewski, Mehmet Tanol, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
September 26, 2021
SIGIRR Mutation in Human Necrotizing Enterocolitis (NEC) Disrupts STAT3-Dependent microRNA Expression in Neonatal Gut
Wei Yu, Inamul Haque, Aparna Venkatraman, et al.
The Journal of Biological Chemistry
|
February 8, 2018
The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling
Gargi Maity, Inamul Haque, Arnab Ghosh, et al.
Research Square
|
June 5, 2025
Targeted Nanoencapsulation of Tunicamycin Reduces Toxicity While Improving its Therapeutic Effectiveness in Pancreatic Cancer Cells
Debasmita Dutta, Sunil Upadhyay, Archana De, et al.
Molecular Therapy. Oncology
|
October 2, 2025
Targeted nanoencapsulation of tunicamycin reduces toxicity while improving its therapeutic effectiveness in pancreatic cancer cells
Debasmita Dutta, Sunil P Upadhyay, Archana De, et al.
Molecular Cancer Therapeutics
|
February 22, 2019
CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma
Gargi Maity, Arnab Ghosh, Vijayalaxmi Gupta, et al.
Page
of 5